a selective norepinephrine reuptake inhibitor intended for oral administration only. It is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents and adults.Learn more
is indicated for the treatment of major depressive disorder,diabetic neuropathic pain, generalized anxiety disorder.Learn more
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and other psychoses where positive symptoms (e.g., delusions, hallucinations, disordered thinking, hostility, and suspiciousness) and/or negative symptoms (e.g., flattened affect, emotional and social withdrawal, poverty of speech) are prominent. Olanzapine also alleviates the secondary affective symptoms commonly associated with schizophrenia and related disorders.
Olanzapine is effective in maintaining the clinical improvement during continuing therapy in patients who have shown initial treatment response.
Olanzapine as monotherapy or in combination with lithium or valproate is indicated for the treatment of acute manic or mixed episodes in bipolar disorder with or without psychotic features and with or without a rapid cycling course.
Olanzapine is indicated for the prevention of recurrence in patients with bipolar mania.Learn more